Skip to content

Long-Term Clinical Efficacy of Corneal Cross-Linking for the Treatment of Ectatic Corneal Disorders

Long-Term Clinical Efficacy of Corneal Cross-Linking for the Treatment of Ectatic Corneal Disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117220
Enrollment
Unknown
Registered
2026-01-21
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progressive corneal thinning, abnormal collagen fibril architecture, and progressively increasing curvature lead to irregular astigmatism and severe visual deterioration.

Interventions

Observation group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with ectatic corneal disorders undergoing CXL for the first time at any age. 2.Postoperative follow-up of at least 1 year, with the last visit >=5 years after surgery.

Exclusion criteria

Exclusion criteria: 1.Prior corneal procedures (e.g., intrastromal corneal ring segments, excluding laser corneal refractive surgery), intraocular surgery, or glaucoma surgery. 2.Comorbid glaucoma; 3.Severe infection; 4.Comorbid autoimmune disease;

Design outcomes

Primary

MeasureTime frame
Postoperative maximum keratometry (Kmax);

Secondary

MeasureTime frame
Other corneal topographic parameters;Visual function parameters;Disease progression rate;

Countries

China

Contacts

Public ContactZhang Jia

Eye Hospital, Wenzhou Medical University

653321886@qq.com+86 577 88068888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026